Allergan plc (NYSE:AGN)

188.19
Delayed Data
As of Jan 24
 -2.41 / -1.26%
Today’s Change
114.27
Today|||52-Week Range
194.61
-1.56%
Year-to-Date
Is Mylan Stock a Buy?
6:00am / MotleyFool.com - Paid Partner Content
Better Buy: Abbott Laboratories vs. AbbVie
Jan 19 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie vs. Johnson & Johnson
Jan 24 / MotleyFool.com - Paid Partner Content
Why AbbVie Stock Dipped in 2019
Jan 16 / MotleyFool.com - Paid Partner Content
Double Your Money with This Biotech
Jan 24 / MotleyFool.com - Paid Partner Content
5 Key Things Investors Should Look Forward to With AbbVie in 2020
Jan 16 / MotleyFool.com - Paid Partner Content
Why Long-Term Investors Should Avoid TEVA Stock Like the Plague
Jan 22 / MotleyFool.com - Paid Partner Content
Why AbbVie Could Be a Great Buy in 2020
Jan 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close190.60
Today’s open190.00
Day’s range187.82 - 190.39
Volume3,447,097
Average volume (3 months)2,305,663
Market cap$63.2B
Data as of 6:30pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)-15.70%
Earnings growth (this year)+1.38%
Earnings growth (next 5 years)+6.10%
Revenue growth (last year)-0.96%
P/E ratioNM
Price/Sales2.85
Price/Book0.98

Competitors

 Today’s
change
Today’s
% change
TAKTakeda Pharmaceutica...-0.19-0.95%
VRTXVertex Pharmaceutica...-4.85-2.07%
ZTSZoetis Inc-2.03-1.47%
----
Data as of 6:30pm ET, 01/24/2020

Financials

Next reporting dateFebruary 19, 2020
EPS forecast (this quarter)$4.56
Annual revenue (last year)$15.8B
Annual profit (last year)-$5.1B
Net profit margin-32.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts